Trial · NCT04818450
Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient
NCT04818450, Not applicable, Completed, Mahidol University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient. Trials, record NCT04818450. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04818450
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Impact of Gabapentin on Slow Wave Sleep in Adult Critically Ill Patient
- NCT number
- NCT04818450
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- Mahidol University
- Conditions
- Sleep Deprivation, Critically Ill
- Interventions
- Gabapentin
- First posted
- 2021-03-26
- Last updated
- 2022-08-11
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Slow-wave sleep | at least 3 consecutive days after randomization | Slow-wave sleep period or deep sleep period |
| Secondary | All-cause hospital mortality | During hospital stay or death or a maximum of 90 days | Rates of all-cause mortality during hospital stay |
| Secondary | ICU free days | During ICU stay or death or a maximum of 28 days | Days alive and not stay in ICU |
| Secondary | Mechanical ventilator free days | During ICU stay or death or a maximum of 28 days | Day alive and free of mechanical ventilator |
| Secondary | Hospital free days | During hospital stay or death or a maximum of 90 days | Days alive and not stay in hospital |
| Secondary | Incidence of self-extubation | During ICU stay or death or a maximum of 28 days | Number of patients who had self-extubation during ICU stay |
| Secondary | Incidence of sleep deprivation | During ICU stay or death or a maximum of 28 days | Times per patient-days of sleep deprivation during ICU stay |
| Secondary | Delirium free day | During ICU stay or death or a maximum of 28 days | Days alive and not having delirium |
| Other | IGF-1 | At day 0, 1, 3, and 5 after randomization | IGF-1 level |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers8
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04818450
GET https://conductscience.org/api/trials/v1/NCT04818450/registered